ABBOTT LABORATORIES — Director's Dealing 2008

Sep 3, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-08-28

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-08-28	Common shares without par value	M	2378	$44.6124	Acquired	146256	Direct
2008-08-28	Common shares without par value	M	12200	$45.4488	Acquired	158456	Direct
2008-08-28	Common shares without par value	F	12681	$57.72	Disposed	145775	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-08-28	Option (right to buy)	$44.6124	M	2378	Disposed	2011-07-08	Common shares (2378)	Direct
2008-08-28	Option (right to buy)	$45.4488	M	12200	Disposed	2011-02-08	Common shares (12200)	Direct
2008-08-28	Option (right to buy)	$57.72	A	2051	Acquired	2011-07-08	Common shares (2051)	Direct
2008-08-28	Option (right to buy)	$57.72	A	10630	Acquired	2011-02-08	Common shares (10630)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	14091	Indirect
Common shares without par value	295	Indirect
Common shares without par value	296	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 28, 2008.

F2: The reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.